Learn More2023-06-06 12:00:002023-06-06 13:00:00America/New_YorkPenn Bioethics Seminar (PBS): Ableism in Biomedical Research with Maya Sabatello, LLB, PhD
Ableism in Biomedical Research
Maya Sabatello, LLB, PhD
Associate Professor of Medical Sciences, Columbia University
Inclusion of diverse populations in biomedical research makes for good science and fosters equity in research participation, but “diversity” has often been interpreted narrowly to only encompass marginalized gender, racial and ethnic groups. This presentation explores diversity in biomedical research and its relevance for the heterogenous group of people with disability. It will share findings from studies on inclusion in clinical trials and precision medicine research, discuss challenges and ramifications, and consider the bioethical issues that arise.
Virtual via ZoomPenn Medical Ethics
Learn More2023-06-13 12:00:002023-06-13 13:00:00America/New_YorkPenn Bioethics Seminar (PBS): Behavioral Interventions to Promote Adherence to Guidelines with Catherine Pollak, PhD
Behavioral Interventions to Promote Adherence to Guidelines
Catherine Pollak, PhD
Harkness Fellow in Health Care Policy and Practice, MEHP, PSOM
Lunch is provided for in-person attendees.
Livestreaming available via Zoom.
Catherine Pollak, PhD, is a senior economist at the Direction for Statistics, Research and Evaluation at the Ministry of Health in France. She is currently a 2022/23 Harkness Fellow in Policy and Practice of The Commonwealth Fund, based at NYU Grossman School of Medicine and CHIBE University of Pennsylvania. This presentation will discuss two ongoing randomized controlled trials that use behavioral insights to promote adherence to clinical guidelines.
Hybrid! 1402 Blockley Hall, 423 Guardian Drive and via ZoomPenn Medical Ethics
Learn More2023-06-14 12:00:002023-06-14 13:00:00America/New_YorkResearch Ethics and Policy Series (REPS): The Burden of Uncertainty: Raising Regulatory Standards to Improve Health Equity with Reshma Ramachandran, MD, MPP, MHS
The Burden of Uncertainty: Raising Regulatory Standards to Improve Health Equity
Reshma Ramachandran, MD, MPP, MHS
Assistant Professor of Medicine (General Medicine),
School of Medicine, Yale University
Co-sponsored by the Department of Family Medicine and Community Health at the Perelman School of Medicine
Lunch is provided for in-person attendees.
Livestreaming available via Zoom.
Reshma Ramachandran, MD, MPP, MHS is a board-certified family physician and health services researcher. Her research focuses on the realignment of incentives for healthcare stakeholders including pharmaceutical companies, hospitals, and universities towards prioritizing equitable patient access to safe, effective health technologies.
Recently, the U.S. Food and Drug Administration (FDA) has been placing greater emphasis and implementing reforms focused on improving health equity. The focus of the reforms has been largely on increasing representation in clinical trials, enhancing transparency and access to available data on the effect of medical products on minority populations, and promoting health and safety communication to these populations. Concurrently, FDA continues to increasingly adopt regulatory flexibility in their review process, accepting less rigorous evidence as the basis of approval of novel medical products. In the case of accelerated approval, the agency allows for residual uncertainty at the time of approval, but then requires sponsors to complete additional studies that confirm clinical benefit in a timely manner; should these not be completed or if the studies yield negative results, FDA can withdraw these drugs from the market. However, the expanded and more flexible use of this pathway by the FDA has raised questions about which communities will bear the burden of such uncertainty and whether this may in fact exacerbate health disparities.
In this presentation, Dr. Ramachandran will discuss trends in FDA’s adoption of regulatory flexibility in the approval of novel medical predicts, the implication of such policies, and proposals to center health equity in regulatory decision-making.
RCH B102AB, Richards Building, 3700 Hamilton WalkPenn Medical Ethics
Learn More2023-06-20 12:00:002023-06-20 13:00:00America/New_YorkPenn Bioethics Seminar (PBS): Youth Caregivers in the United States: Prevalence and the Association Between Caregiving and Education
Youth Caregivers in the United States: Prevalence and the Association Between Caregiving and Education
Katherine Miller, PhD
Postdoctoral Research Fellow, MEHP, PSOM
Family caregivers are the primary providers of long-term care in the United States yet there are limited federal policy supports, despite the known short- and long-term negative impacts of caregiving. Limited information about the prevalence of youth/young adult caregivers, their characteristics, or the impacts of caregiving at formative ages exists in the US. Our objective is to estimate the prevalence of youth caregivers and examine the association of caregiving with educational investments. We use the American Time Use Survey (2013-2019) to identify and describe youth caregivers (aged 15-18) and young adult caregivers (aged 19-15) compared to non-caregiving peers. We estimate 985,988 youth caregivers and 1,897,952 young adult caregivers, which corresponds to approximately 4.1% and 4.7% of the population in these age groups, respectively. Compared to non-caregiving peers, both youth and young adult caregivers are less likely to be enrolled in school and, among those enrolled in school, spend significantly less time on educational activities. Considering the association of caregiving among youth/young adults and education, policies supporting youth/young adult caregivers are critical.
Virtual via ZoomPenn Medical Ethics